Market Research Logo

Venous Thromboembolism Global Clinical Trials Review, H2, 2016

Venous Thromboembolism Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016 provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Venous Thromboembolism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Venous Thromboembolism
Nov 14, 2016: Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically III Patients with Extended-Duration Betrixaban
Nov 07, 2016: Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data to be Presented at American Heart Association Scientific Sessions 2016
Nov 03, 2016: Janssen To Present Data On Rivaroxaban At 58th American Society of Hematology Annual Meeting
Oct 23, 2016: Two New Real-World Studies Confirm Positive Efficacy and Safety Profile of XARELTO (rivaroxaban) in Treating and Preventing Blood Clots
Aug 24, 2016: Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion Among 13 Daiichi Sankyo Clinical Presentations at ESC Congress 2016
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Region, 2016*
Thymic Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
Thymic Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Europe, Top Countries, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2016*
Proportion of Thymic Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2016*
Thymic Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
Thymic Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
Proportion of Thymic Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2016*
Thymic Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2016*
Thymic Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
Thymic Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Thymic Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
Thymic Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
List of Figures
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Region (%), 2016*
Venous Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2016*
Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2016*
Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Phase (%), 2016*
Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
Venous Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
GlobalData Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report